Compare ANL & SVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANL | SVC |
|---|---|---|
| Founded | 2004 | 1995 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 998.8M | 839.2M |
| IPO Year | 2022 | 1995 |
| Metric | ANL | SVC |
|---|---|---|
| Price | $10.74 | $6.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $29.50 | $12.19 |
| AVG Volume (30 Days) | 310.2K | ★ 2.4M |
| Earning Date | 08-14-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 3.28% |
| EPS Growth | N/A | ★ 26.95 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,814,838,000.00 |
| Revenue This Year | $243.83 | N/A |
| Revenue Next Year | N/A | $3.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.88 | $1.13 |
| 52 Week High | $17.25 | $9.02 |
| Indicator | ANL | SVC |
|---|---|---|
| Relative Strength Index (RSI) | 36.09 | 45.70 |
| Support Level | $8.96 | $5.65 |
| Resistance Level | $12.49 | $6.87 |
| Average True Range (ATR) | 1.45 | 0.49 |
| MACD | -0.40 | 0.02 |
| Stochastic Oscillator | 5.63 | 24.07 |
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.
Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its segments hotel investment unit, and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza, Hyatt Place, and others.